Remune
- Generic Name
- Remune
- Drug Type
- Biotech
Evaluating the Combined Intervention of Nutritional Supplementation (Remune) and Exercise in Patients With Cancer Cachexia
Phase 1
Completed
- Conditions
- Weight LossLung CancerCachexia; CancerGastrointestinal Cancer
- Interventions
- Other: EXCAP©®
- First Posted Date
- 2019-10-18
- Last Posted Date
- 2023-08-15
- Lead Sponsor
- University of Rochester
- Target Recruit Count
- 25
- Registration Number
- NCT04131426
- Locations
- 🇺🇸
University of Rochester, Rochester, New York, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath